Atlas market file · Equity · United States
Nanoviricides, Inc.NNVC
- Last close
- 1.42
- Change
- +1.43%
- 96-bar range
- 0.87 – 1.93
- As of
- 7 Aug 2026
Nanoviricides, Inc. is a pharmaceutical preparations issuer listed as NNVC on AMEX. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
NNVC
Equity · evidence first
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (-25.26% over the window).
Source rail: Yahoo Finance chart API (NNVC). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for NNVC. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
NNVC public profile
Pharmaceutical preparations issuer. Nanoviricides, Inc. is connected to current market context, cited company sources and its retained research file.
Nanoviricides, Inc. trades as NNVC on AMEX. Nanoviricides, Inc. (NNVC) has a latest verified close of 1.42, up 1.43%, dated 7 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files NNVC under USA Stocks for browsing.
What changed for Nanoviricides, Inc. today
Nanoviricides Inc. (NNVC) is a biotechnology company focused on developing antiviral drugs using its proprietary nanoviricides platform technology. The company's latest financial filings reveal a challenging financial environment, with a net loss of $2.0 million for the quarter ending March 31, 2026. This loss is mirrored in the company's operating income, which also stands at a negative $2.0 million. Despite these financial challenges, the company continues to invest in its research and development, with $1.3 million spent on R&D during the same period.
The nanoviricides platform technology is designed to create a class of drugs called nanoviricides, which are engineered to attack and neutralize viruses. The company's extensive library of synthesized compounds and know-how suggests a deep commitment to its scientific mission. However, the financial reality is that the company is burning through cash, with net cash used in operating activities amounting to $5.6 million for the quarter.
The company's balance sheet shows assets of $10.2 million and liabilities of $1.1 million, with cash and cash equivalents at $3.2 million. This financial position, combined with the company's ongoing losses, highlights the need for continued financing to support its operations and research. The company's earnings per share, diluted, stand at $-0.09, reflecting the financial strain.
Nanoviricides Inc. trades on the OTCQB market, and its financial performance is a key indicator of its ability to continue developing its antiviral drugs. The company's ability to secure additional financing will be crucial in determining its long-term viability and success in bringing its nanoviricides platform to market.
Sources & evidence · 10 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
NNVC technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on NNVC
FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep NNVC research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
NNVC FAQ
What is Nanoviricides, Inc. (NNVC)?Nanoviricides, Inc. (NNVC) has a latest verified close of 1.42, up 1.43%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed...
Nanoviricides, Inc. (NNVC) has a latest verified close of 1.42, up 1.43%, dated 7 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for NNVC?Nanoviricides, Inc. (NNVC) has a latest verified close of 1.42, up 1.43%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks...
Nanoviricides, Inc. (NNVC) has a latest verified close of 1.42, up 1.43%, dated 7 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files NNVC under USA Stocks for browsing.
How often is the NNVC page updated?The NNVC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The NNVC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for NNVC?The NNVC file starts with SEC EDGAR filings, Nasdaq Trader and TradingView AMEX:NNVC. SEC EDGAR provides the filing anchor for this issuer. The page separates verified...
The NNVC file starts with SEC EDGAR filings, Nasdaq Trader and TradingView AMEX:NNVC. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on NNVC?Yes. The workstation can open NNVC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open NNVC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this NNVC page investment advice?No. The NNVC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The NNVC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →